Error: Bad annotation destination
United States Court of Appeals for the Federal Circuit
05-1043
CROSS MEDICAL PRODUCTS, INC.,
Plaintiff-Appellee,
v.
MEDTRONIC SOFAMOR DANEK, INC.
and MEDTRONIC SOFAMOR DANEK USA, INC.,
Defendants-Appellants.
Bruce D. Kuyper, Latham & Watkins, LLP, of Los Angeles, California, argued for
plaintiff-appellee. With him on the brief were Brian F. McMahon; Mark A. Finkelstein,
Allan Z. Litovsky, and Jordan B. Kushner of Costa Mesa, California.
Dirk D. Thomas, Robins, Kaplan, Miller & Ciresi L.L.P., of Washington, DC,
argued for defendants-appellants. With him on the brief were Robert A. Auchter; Jan M.
Conlin and Munir R. Meghjee, of Minneapolis, Minnesota.
Appealed from: United States District Court for the Central District of California
Senior Judge Gary L. Taylor
United States Court of Appeals for the Federal Circuit
05-1043
CROSS MEDICAL PRODUCTS, INC.,
Plaintiff-Appellee,
v.
MEDTRONIC SOFAMOR DANEK, INC.
and MEDTRONIC SOFAMOR DANEK USA, INC.,
Defendants-Appellants.
__________________________
DECIDED: September 30, 2005
__________________________
Before SCHALL, GAJARSA, and LINN, Circuit Judges.
LINN, Circuit Judge.
Medtronic Sofamor Danek, Inc. et al. (“Medtronic”) appeals from an order of the
United States District Court for the Central District of California (“district court”)
permanently enjoining Medtronic from infringing claim 5 of U.S. Patent No. 5,474,555
(“the ’555 patent”) owned by Cross Medical Products, Inc. (“Cross Medical”). See Cross
Med. Prods., Inc. v. Medtronic Sofamor Danek, Inc., No. SA CV 03-110-GLT(ANx) (C.D.
Cal. Sept. 28, 2004). The permanent injunction was issued following the grant of Cross
Medical’s motions for partial summary judgment of validity and infringement. See Cross
Med. Prods., Inc. v. Medtronic Sofamor Danek, Inc., No. SA CV 03-110-GLT(ANx) (C.D.
Cal. Aug. 19, 2004) (“Invalidity Opinion”); Cross Med. Prods., Inc. v. Medtronic Sofamor
Danek, Inc., No. SA CV 03-110-GLT(ANx) (C.D. Cal. May 20, 2004) (“Infringement
Opinion”). As a threshold matter, we conclude, over Cross Medical’s objection, that we
have jurisdiction over this appeal. On Medtronic’s challenge to the district court’s claim
construction rulings, we affirm the district court’s construction of the “anchoring means,”
“securing means,” and “bear against said channel” limitations, but modify the district
court’s construction of the “anchor seat means” and “operatively joined” limitations.
Because we find genuine issues of material fact regarding infringement, we reverse the
grant of Cross Medical’s motion for partial summary judgment of infringement and find
no abuse of discretion in the denial of Medtronic’s cross-motion for partial summary
judgment of non-infringement. We also reverse the grant of Cross Medical’s motion for
partial summary judgment that claim 5 is not obvious but affirm the grant of that motion
as to indefiniteness and anticipation. We further conclude that the district court did not
abuse its discretion in denying Medtronic’s cross-motion for summary judgment as to
these invalidity issues. Consequently, we vacate the permanent injunction. Thus, we
affirm-in-part, reverse-in-part, vacate-in-part, and remand.
I. BACKGROUND
This appeal involves orthopedic surgical implants used to stabilize and align the
bones of a patient’s spine. A common problem with spinal fixation is determining how to
secure the fixation device to the spine without damaging the spinal cord. Methods of
fixation have developed which utilize wires that extend through the spinal canal and hold
a rod against the lamina,1 or that utilize pedicular screws which extend into the pedicle2
1
The “lamina” is part of the neural arch of a vertebra extending from the
pedicle to the median line.
2
The “pedicle” is the basal part of each side of the neural arch of a vertebra
connecting the laminae with the centrum.
05-1043 2
and secure a plate which extends across vertebral segments. The system taught in
U.S. Patent No. 4,805,602 (“the ’602 patent”), which is also assigned to Cross Medical
and is part of the case against Medtronic but not involved in this appeal, exemplifies the
advantages of both methods. The screw and rod system of the ’602 patent provides a
rigidity which is intermediate between wired implant and plate systems. Several screw
and rod systems are known in the art. Those which feature an anchor secured to the
bone by a separate screw are termed “polyaxial.” Polyaxial screws have a capability of
pivoting in the anchor. Devices in which the anchor and the bone screw form a unitary
body are deemed “monoaxial.” Monoaxial screws have no ability to pivot relative to the
anchor.
Cross Medical’s ’555 patent discloses a device, an embodiment of which is
illustrated in Figures 1, 2, and 3 below:
The ’555 device allows a surgeon to place a series of bone screws 21, each
carrying an anchor seat 23, into the bones of a patient. A stabilization rod 18 thereafter
may be positioned in the channels 51, 52 of the anchor seats. The ’555 device allows
05-1043 3
surgeons to secure the rod to the anchor seats with top-tightening nuts 27. By
connecting the rod in this fashion to the anchors on adjacent spinal bones, the position
of the patient’s spine may be fixed as desired by the surgeon.
On February 4, 2003, Cross Medical filed suit alleging that certain of Medtronic’s
polyaxial screws—MAS, Vertex, M8, Sextant, M10, Legacy 4.5, and Legacy 5.5—
infringe the ’555 patent and U.S. Patent No. 5,466,237 (“the ’237 patent”). The accused
devices employ a “set screw,” which features external threads to mate with the receiver
member’s internal threads, to hold the rod in the receiver member. The accused
devices also include a “crown member” that lies between the rod and the bone screw.
An illustration of the accused device follows, with explanatory text added.
Medtronic denied infringement and counterclaimed seeking a declaratory
judgment of non-infringement and invalidity. Subsequent to the initial pleading,
responses and amended pleadings added claims and counterclaims relating to several
additional patents, including the ’602 patent. The district court resolved several issues
through summary adjudication. Of importance to this appeal, the district court
05-1043 4
separately entertained motions for partial summary judgment of infringement and
validity of claim 5 of the ’555 patent.
Claim 5 recites:
A fixation device for the posterior stabilization of one or more bone
segments of the spine, comprising:
at least two anchors and an elongated stabilizer comprising a rod
having a diameter and a longitudinal axis, said anchors each
comprising anchoring means which secure said anchors to said bone
segment and an anchor seat means which has a lower bone interface
operatively joined to said bone segment and an anchor seat portion
spaced apart from said bone interface including a channel to receive
said rod; and
securing means which cooperate with each of said anchor seat portions
spaced apart from said bone interface and exterior to the bone relative
to said elongated rod, said seat means including a vertical axis and first
threads which extend in the direction of said vertical axis toward said
lower bone interface to a depth below the diameter of the rod when it is
in the rod receiving channel, and said securing means including second
threads which cooperate with the first threads of the seat means to
cause said rod to bear against said channel through the application of
substantially equal compressive forces by said securing means in the
direction of the vertical axis and applied on either side along said
longitudinal axis of said channel.
’555 patent, col. 8, ll. 33-57 (emphases added).
On May 29, 2004, the district court construed the “operatively joined,” “securing
means,” and “bear against said channel” limitations of claim 5 of the ’555 patent. Based
on these constructions, the court granted Cross Medical’s motion for partial summary
judgment of infringement, and denied Medtronic’s cross-motion for partial summary
judgment of non-infringement. On August 19, 2004, the district court additionally
construed the “anchor seat means” and “anchoring means” limitations of claim 5 of the
’555 patent. The court then denied Medtronic’s motion for partial summary judgment
that claim 5 was anticipated, obvious, and indefinite, and granted Cross Medical’s
05-1043 5
cross-motion for partial summary judgment that claim 5 was neither anticipated,
obvious, nor indefinite.
On September 28, 2004, with proceedings still on-going with respect to the ’555
patent and other patents-in-suit, the district court granted Cross Medical’s motion for a
permanent injunction to preclude Medtronic’s infringement of claim 5 of the ’555 patent.
The district court presumed irreparable harm because Cross Medical had prevailed on
the merits at the summary judgment stage. Medtronic argued that there could be no
harm because it withdrew all of the asserted infringing devices from the market;
however, the district court found that some of the infringing products remained available
and that Medtronic had the capacity to bring infringing product back to market. On
October 4, 2004, the district court stayed the injunction for 90 days to allow Medtronic
time to appeal.
On October 13, 2004, Medtronic appealed from the order granting the injunction,
asserting jurisdiction under 28 U.S.C. § 1292(a)(1), (c)(1). Medtronic asks this court to
review the district court’s claim construction rulings, reverse or vacate the district court’s
partial summary judgment orders on infringement, indefiniteness, anticipation, and
obviousness with respect to claim 5 of the ’555 patent, and vacate the permanent
injunction. On November 19, 2004, Cross Medical filed a motion to dismiss this appeal
for lack of jurisdiction.
05-1043 6
II. DISCUSSION
A. Jurisdiction
“Whether this court has jurisdiction over an appeal taken from a district court
judgment is a question of law which we address in the first instance.” Pause Tech. LLC
v. TiVo Inc., 401 F.3d 1290, 1292 (Fed. Cir. 2005). Section 1292(a)(1) provides that the
court of appeals has jurisdiction over appeals from interlocutory orders “granting,
continuing, modifying, refusing or dissolving injunctions, or refusing to dissolve or
modify injunctions.” 28 U.S.C. § 1292(a)(1) (2000). Section 1292(c)(1) provides this
court exclusive jurisdiction over an appeal of an interlocutory order granting an
injunction if we would otherwise have jurisdiction under § 1295. Id. § 1292(c)(1).
Medtronic appeals from an order permanently enjoining Medtronic from infringing the
’555 patent. On its face, the order falls within the scope of § 1292(a)(1), (c)(1).
Cross Medical argues that under Woodard v. Sage Products, Inc., 818 F.2d 841
(Fed. Cir. 1987) (en banc), this court does not possess jurisdiction because the
injunction is one in form but not substance. Cross Medical asserts that the injunction is
not coercive because it enjoins Medtronic from engaging in activities it had abandoned
before the injunction issued. Cross Medical asserts that Medtronic simply should have
sought a stay of the injunction pending appeal under Federal Rule of Appellate
Procedure 8(a). Alternatively, Cross Medical argues that even if the court has
jurisdiction to review the order, it has no jurisdiction to reverse or vacate the partial
summary judgment rulings because no final judgment on the ’555 patent has been
entered, and the orders were not certified for appeal.
05-1043 7
Medtronic counters that the order falls under § 1292(a)(1), (c)(1). Medtronic
asserts that Sage Products is inapposite and that no case has denied jurisdiction in an
appeal from the grant of an injunction. Medtronic states that Cross Medical argued
below that the injunction was necessary to prevent irreparable harm, that Medtronic
pulled products from the market to avoid a willfulness finding, that the district court
entered the injunction with full knowledge of Medtronic’s actions, and that it would be
unfair to deny Medtronic its statutory right of appeal.
Cross Medical’s reliance on Sage Products is misplaced. In Sage Products,
plaintiff’s amended complaint included a prayer for injunctive relief, and the issue was
whether plaintiff could lodge an appeal under § 1292(a)(1) from an order granting
defendant’s motion for summary judgment of non-infringement. 818 F.2d at 843-44.
There was no order specifically denying injunctive relief. Id. Instead, plaintiff argued
that the adverse summary judgment ruling had the effect of denying injunctive relief. Id.
at 844. This court sitting en banc considered the impact of the Supreme Court’s then
recent decision in Carson v. American Brands, Inc., 450 U.S. 79 (1981). We explained
that Carson “instructed that an interlocutory appeal under section 1292(a)(1) requires
(a) that the order be injunctive in nature, (b) that it cause a serious, if not irreparable,
consequence, and (c) that the order can be effectively challenged only by immediate
appeal.” Sage Products, 818 F.2d at 849. We held that Woodard failed to establish
that the order met the Carson requirements. Id. at 855.
However, in reporting on how other courts interpreted Carson, we criticized the
Seventh Circuit for applying “the Carson requirements to an order explicitly granting an
injunction,” observing that “the Supreme Court in Carson expressly limited its holding to
05-1043 8
orders that have ‘the practical effect of refusing an injunction.’” Id. at 850 n.6 (quoting
Carson, 450 U.S. at 84). We explained that “as a rule of general applicability to orders
deemed to deny injunctions, the Carson rule is workable and sensibly balances the
statutory provisions of sections 1291 and 1292(a)(1) in light of their respective
purposes.” Id. at 853. The Supreme Court subsequently confirmed our reading of
Carson as applying only to orders that have “the practical effect of granting or denying
injunctions.” Gulfstream Aerospace Corp. v. Mayacamas Corp., 485 U.S. 271, 287-88
(1988) (“Section 1292(a)(1) will, of course, continue to provide appellate jurisdiction
over orders that grant or deny injunctions and orders that have the practical effect of
granting or denying injunctions and have ‘“serious, perhaps irreparable, consequence.”’”
(quoting Carson, 450 U.S. at 84 (quoting Baltimore Contractors, Inc. v. Bodinger, 348
U.S. 176, 181 (1955)))); see also 19 James Wm. Moore et al., Moore’s Federal Practice
¶ 203.10[2][a], at 12 (3d ed. 2005) (“Moore’s”) (“While the statute clearly applies to
orders that formally grant injunctive relief, it also authorizes interlocutory appeals from
orders that have the practical effect of granting an injunction.”). Therefore, “if the district
court’s order expressly grants an injunction, the order is appealable under § 1292(a)(1),
without regard to whether the appellant is able to demonstrate serious or irreparable
consequences.” Moore’s ¶ 203.10[2][a], at 14.
In this case, the district court entered an order expressly enjoining Medtronic
from infringing claim 5 of the ’555 patent. Thus, Carson is inapplicable. See PIN/NIP,
Inc. v. Platte Chem. Co., 304 F.3d 1235, 1242 (Fed. Cir. 2002) (finding jurisdiction
without referring to the Carson test because “[t]he district court’s grant of a permanent
injunction . . . [brought the] appeal squarely within the confines of § 1292(a)(1)”). On
05-1043 9
appeal from the district court’s grant of the injunction, we have jurisdiction under 28
U.S.C. § 1292(a)(1).
Moreover, we may review the underlying partial summary judgment orders
because they are inseparably connected to the merits of the permanent injunction. See
id. at 1242-48 (reviewing a summary judgment ruling that a claim was not anticipated by
the prior art where jurisdiction was based on § 1292(a)(1), (c)(1)); Katz v. Lear Siegler,
Inc., 909 F.2d 1459, 1461 (Fed. Cir. 1990) (reviewing propriety of joinder of counter-
defendant on appeal from injunction); Moore’s ¶ 203.10[7][b], at 45-47 (“[An
interlocutory appeal under § 1292(a)(1)] enable[s] the circuit court to review other orders
that are inseparably or very closely connected with the merits of the injunctive
order . . . .”). The district court presumed irreparable harm based on Cross Medical’s
success on the merits, which manifested itself in the summary judgment orders
concerning claim 5. Because Cross Medical’s success on the merits turns on the
propriety of the summary judgment rulings, our review of the grant of the permanent
injunction requires that we rule on the summary judgment orders. See Mendenhall v.
Barber-Green Co., 26 F.3d 1573, 1581 n.12 (Fed. Cir. 1994) (noting “that an
interlocutory appeal from a permanent injunction, to the extent that it considers
questions of validity and infringement . . . is identical in substance to an appeal brought
under § 1292(c)(2)”). The cases cited by Cross Medical are not germane.
For these reasons, Cross Medical’s motion to dismiss the appeal for lack of
jurisdiction is denied.
05-1043 10
B. Standard of Review
“We review the grant of a permanent injunction for an abuse of discretion which
requires plenary review of the correctness of . . . rulings on matters of law.” Stratos
Mobile Networks USA, LLC v. United States, 213 F.3d 1375, 1379 (Fed. Cir. 2000)
(internal quotations omitted). We review the grant of a motion for summary judgment de
novo. Id. However, we review the denial of a motion for summary judgment for abuse
of discretion. Gart v. Logitech, Inc., 254 F.3d 1334, 1338 (Fed. Cir. 2001). Summary
judgment should only be granted “if the pleadings, depositions, answers to
interrogatories, and admissions on file, together with the affidavits, if any, show that
there is no genuine issue as to any material fact and that the moving party is entitled to
a judgment as a matter of law.” Fed. R. Civ. P. 56(c). In applying this standard, “[t]he
evidence of the non-movant is to be believed, and all justifiable inferences are to be
drawn in [the non-movant’s] favor.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255
(1986). “The fact that both the parties have moved for summary judgment does not
mean that the court must grant summary judgment to one party or the other. . . . Cross-
motions are no more than a claim by each party that it alone is entitled to summary
judgment, and the court must evaluate each motion on its own merits, taking care in
each instance to view the evidence in favor of the nonmoving party.” Bubble Room, Inc.
v. United States, 159 F.3d 553, 561 (Fed. Cir. 1998) (internal citation omitted); accord
Gart, 254 F.3d at 1338-39.
Claim construction is a question of law reviewed de novo. See Phillips v. AWH
Corp., 415 F.3d 1303, 1328 (Fed. Cir. 2005) (en banc). Determination of infringement is
a factual question. Bai v. L & L Wings, Inc., 160 F.3d 1350, 1353 (Fed. Cir. 1998).
05-1043 11
“Indefiniteness, . . . like claim construction, is a question of law that we review de novo.”
Atmel Corp. v. Info. Storage Devices, 198 F.3d 1374, 1378 (Fed. Cir. 1999).
Anticipation is a question of fact. Advanced Display Sys., Inc. v. Kent State Univ., 212
F.3d 1272, 1281 (Fed. Cir. 2000). “Obviousness is a question of law based on
underlying facts.” Group One Ltd. v. Hallmark Cards, Inc., 407 F.3d 1297, 1303 (Fed.
Cir. 2005).
C. Claim Construction
In the course of its rulings on partial summary judgment for both infringement and
validity, the district court construed the “anchoring means,” “anchor seat means,”
“operatively joined,” “securing means,” and “bear against said channel” limitations of
claim 5. Medtronic challenges each construction.
1. “anchors each comprising anchoring means . . . and anchor seat means”
In the district court, the parties disputed whether either the “anchoring means”
limitation or “anchor seat means” limitation imposed a requirement that the bone screws
be polyaxial. The district court did not construe each limitation separately. Instead, the
district court referred to its prior ruling in Cross Medical Products, Inc. v. DePuy
AcroMed, Inc., No. SA CV 00-876-GLT(ANx), (C.D. Cal. Jan. 9, 2003), and explained
that both the “anchoring means” and “anchor seat means” limitations were in § 112, ¶ 6
form and “must be construed by referring to the specification.” Invalidity Opinion at 3-4.
The district court held that “although the claim language itself does not indicate whether
the screws are polyaxial or monoaxial, the specifications and the drawings establish that
the claims are limited to polyaxial screws.” Id. at 3.
05-1043 12
Medtronic asserts that although the preferred embodiment describes a polyaxial
screw, there is no basis to read this feature into claim 5 because neither “anchoring
means” nor “anchor seat means” are § 112, ¶ 6 limitations. Medtronic argues that even
if these are § 112, ¶ 6 limitations, a monoaxial screw is an alternative embodiment and,
thus, should be considered corresponding structure, citing Micro Chemical, Inc. v. Great
Plains Chemical Co., 194 F.3d 1250 (Fed. Cir. 1999). Medtronic also relies on the
doctrine of claim differentiation, arguing that the recitation in claim 1 of a polyaxial screw
limitation implies that claim 5 does not possess that limitation. Finally, Medtronic adds
that Cross Medical is estopped from denying that claim 5 covers monoaxial screws
because Cross Medical marked its monoaxial screws with the ’555 patent number.
Cross Medical counters that both “anchoring means” and “anchor seat means”
are § 112, ¶ 6 limitations and their corresponding structure is a polyaxial screw. Cross
Medical argues that claim differentiation must give way to a proper § 112, ¶ 6 analysis
and that the court should not consider “marking estoppel” in construing claim 5 because
marking is extrinsic evidence. Cross Medical adds that claims should be construed to
preserve their validity.
The limitations at issue are contained in the following text of claim 5:
said anchors each compris[e] anchoring means which secure said
anchors to said bone segment and an anchor seat means which has a
lower bone interface operatively joined to said bone segment and an
anchor seat portion spaced apart from said bone interface including a
channel to receive said rod. . . .
05-1043 13
. . . said seat means including a vertical axis and first threads which
extend in the direction of said vertical axis toward said lower bone
interface to a depth below the diameter of the rod when it is in the rod
receiving channel . . . .
’555 patent, col. 8, ll. 36-43, 46-51 (emphases added).
a. “anchoring means”
The limitation recites the word “means,” which gives rise to the presumption that
§ 112, ¶ 6 applies. See Rodime PLC v. Seagate Tech., Inc., 174 F.3d 1294, 1302 (Fed.
Cir. 1999). The claimed function of the “anchoring means” is to “secure said anchors to
said bone segment.” ’555 patent, col. 8, ll. 38-39. No structure is recited in the claim to
perform this function. See id., ll. 35-56. Thus, § 112, ¶ 6 applies and the “claim shall be
construed to cover the corresponding structure . . . described in the specification and
equivalents thereof.” 35 U.S.C. § 112, ¶ 6 (2000); Al-Site Corp. v. VSI Int’l, Inc., 174
F.3d 1308, 1320 (Fed. Cir. 1999).
The specification discloses only one embodiment. That embodiment contains a
screw which carries a separate anchor such that “when the screw 21 engages the
anchor seat 23, a limited ball-and-socket joint is formed which permits freedom of
movement between the rod support 23 and the screw 21.” ’555 patent, col. 5, ll. 4-47.
The specification unambiguously states that a feature of the “present invention” is that
“[e]ach anchor seat is secured by a cancellous screw which cooperates through a
sloped bore in the anchor seat so as to provide a limited ball and socket motion.” Id.,
col. 1, l. 65–col. 2, l. 21. It continues:
The present invention utilizes a rod and vertebral anchors which
holds [sic] the rod in position. Each anchor is secured to the vertebrae by
a transpedicular screw member.
....
05-1043 14
. . . [T]he present design utilizes two implant sets on either side of
the spinous processes. Each implant set includes a . . . rod . . . .
Generally, an implant set is used on each side of the spinous
process . . . . The rod is held in position by a stainless steel vertebral
anchor which captures the rods. The anchor has a seat member which is
secured to the vertebrae by a stainless steel transpedicular screw. The
screw is separate from the anchor seat and thus provides for limited
motion between the anchor seat and the vertebrae.
Id., col. 3, ll. 26-67 (emphasis added). The patent discloses no other structure for
securing the anchor to the bone. The patent states that the polyaxial design “acts as a
‘shock-absorber’ to prevent direct transfer of load from the rod to the bone-screw
interface prior to achieving bony fusion, thereby decreasing the chance of failure.” Id.,
ll. 63-67. Thus, the district court was correct both in linking the recited function to the
structure disclosed in the specification and in concluding that the corresponding
structure was polyaxial. Medtronic argues that even if the limitation is a means-plus-
function limitation linked to the disclosed polyaxial structure, the claim nonetheless
should be construed to include alternative structures like monoaxial screws. However,
because there is only one embodiment described in the specification to secure the
anchor to the bone—a polyaxial screw and anchor structure—there is no basis on which
to extend the limitation to cover alternative, non-disclosed structure not shown to be
structurally equivalent. See 35 U.S.C. § 112, ¶ 6; Al-Site, 174 F.3d at 1320.
We reject the parties’ remaining arguments. First, although the doctrine of claim
differentiation suggests that claim 5 should be broader than claim 1, any presumption
that the claims differ with respect to this feature may be overcome by a contrary
construction mandated by the application of § 112, ¶ 6. See Laitram Corp. v. Rexnord,
Inc., 939 F.2d 1533, 1538 (Fed. Cir. 1991) (holding that the doctrine of claim
differentiation yields to an interpretation mandated by § 112, ¶ 6). Second, Medtronic’s
05-1043 15
assertion that “marking estoppel” applies is incorrect. Even if Cross Medical marked
monoaxial screws with the ’555 patent number, such evidence conflicts with the intrinsic
record and has no bearing on our construction. See Phillips, 415 F.3d at 1318 (“[A]
court should discount [extrinsic evidence] that is clearly at odds with the claim
construction mandated by the claims themselves, the written description, and the
prosecution history, in other words, with the written record of the patent.” (internal
quotation omitted)); cf. SmithKline Diagnostics v. Helena Labs. Corp., 859 F.2d 878,
890-91 (Fed. Cir. 1988) (holding that an accused infringer’s mis-marking of a product
could not convert by estoppel an admittedly non-infringing product into an infringing
product). Finally, Cross Medical’s argument that we should consider the validity of
claim 5 in construing the limitation misses the mark. Because the other claim
construction tools unambiguously resolve the claim construction dispute, considering
validity would be improper. Phillips, 415 F.3d at 1327 (“[W]e have limited the maxim [of
construing a claim to preserve its validity] to cases in which ‘the court concludes, after
applying all the available tools of claim construction, that the claim is still ambiguous.’”).
b. “anchor seat means”
While the limitation recites the word “means,” thus giving rise to the presumption
that § 112, ¶ 6 applies, see Rodime, 174 F.3d at 1302, the claim language is sufficiently
structural as to take the limitation out of the ambit of § 112, ¶ 6. Thus, the district court
erred in treating “anchor seat means” as a means-plus-function limitation; however, that
error is harmless with respect to the conclusion that the claim covers polyaxial
structures, based on the district court’s correct construction of the “anchoring means”
limitation, discussed supra.
05-1043 16
2. “operatively joined”
The district court construed “lower bone interface operatively joined to said bone
segment” to mean “connect[ed] during a surgical procedure.” Infringement Opinion at 5.
The district court interpreted “connect” to mean “in contact.” See id. & n.2. The district
court reasoned that because the claim involves a surgical procedure, “operatively”
means “involving surgical operations.” Id. The district court explained that construing
“operatively” to mean “to produce an appropriate effect” would improperly import a
limitation from the specification. Id. at 4-5.
Medtronic argues that the “bone interface” language surrounding the phrase
“operatively joined” requires that there be contact between the bone segment and the
anchor seat. Medtronic asserts that “operatively” means to produce an effect and that
effect is micro-motion, which Medtronic describes as “limited motion” between the
anchor and the bone. Medtronic argues that it would be inconsistent to construe claim 5
to require a polyaxial screw which enables polyaxial movement, but not to require a
micro-motion effect. Medtronic adds that the district court’s construction renders
“operatively” superfluous because the only way to attach the screw to bone is via
surgery.
Cross Medical counters that the “bone interface” is the portion of the anchor seat
that comes into contact with the bone when there is contact, but that “bone interface”
does not require contact. Cross Medical argues that the district court correctly
construed “operatively” to mean “surgically.” Cross Medical asserts that even if we
construe “operatively” to mean “effectively,” the effect is posterior stabilization, not
05-1043 17
micro-motion. Cross Medical adds that “polyaxial” and “micro-motion” are not
synonymous.
The claim recites an “anchor seat means which has a lower bone interface
operatively joined to said bone segment.” ’555 patent, col. 8, ll. 39-42. The claim does
not state explicitly whether the “bone interface” and the “bone segment” must be in
contact. However, we may refer to the dictionary to begin understanding the ordinary
meaning of these claim terms, “so long as the dictionary definition does not contradict
any definition found in or ascertained by a reading of the patent documents.” Phillips,
415 F.3d at 1322-23 (internal quotations omitted). “[B]one” modifies “interface,”
indicating that the anchor seat has a “lower” portion that may share a “common
boundary” with “bone.” See Webster’s Third New Int’l Dictionary 1178 (2002) (defining
“interface”). The term “joined” describes the relationship between the “bone interface”
and the “bone segment.” Use of the word “joined” indicates that the “interface” and the
“bone” must be brought together or connected to form a single unit, a whole, or a
continuity, and thus that the interface and the bone are in contact. See id. at 1218
(defining “join”).
The written description confirms that the interface must contact the bone. The
screw is separate from the anchor seat, which prevents the direct transfer of load from
the rod to the “bone-screw interface,” and decreases the chance of failure of the “bone-
screw interface.” Id., col. 3, ll. 19-22, ll. 64-67. This use of the term “interface” is
consistent with its meaning a “common boundary” between two parts. Moreover, the
patent refers to the “anchor” as being held, ’555 patent, Abstract, or “secured” to the
bone, id., col. 3, ll. 59-60, and to the point of attachment as a “fusion bed,” id., col. 7,
05-1043 18
l. 15. These references suggest contact between the anchor seat and the bone.
Furthermore, to adjust the height of the anchor posterior to the bone, the patent teaches
the addition of washers that are the same diameter as the anchor seat. Id., col. 5, ll. 50-
57. The washers co-act with the anchor seat to function as the bone interface while
elevating the seat. If contact with bone were not contemplated, then there would be
little need to add washers to elevate the seat. The drawings show contact between the
anchor and bone, which is consistent with the description. Id., Figures 3, 14, 17-20.
Because the ordinary meaning of “interface” and “joined,” as reflected in dictionary
definitions and in the overall context of the intrinsic record, leads to the conclusion that a
person of ordinary skill in the art would have understood these terms to require “contact”
between the interface and the bone, the district court’s construction in this regard was
correct. It would be improper to construe “joined” more broadly to mean “connected”
without requiring contact.
As to “operatively,” the term is often used descriptively in patent drafting to mean
“effectively” in describing the functional relationship between claimed components.
See, e.g., Innova/Pure Water, Inc. v. Safari Water Filtration Sys., Inc., 381 F.3d 1111,
1118 (Fed. Cir. 2004) (“[Operatively connected] is a general descriptive term frequently
used in patent drafting to reflect a functional relationship between claimed
components.”). Here, the preamble of the claim recites that the invention is operative
when it effects posterior stabilization of one or more bone segments of the spine. ’555
patent, col. 8, ll. 33-34; see Innova, 381 F.3d at 1118 (declining to decide whether
preamble was an affirmative limitation, but recognizing that preamble recited the
intended use corresponding to “operatively”). The body of the claim is consistent as it
05-1043 19
calls for anchors and a stabilizer rod, and provides detail on how these structures
interrelate to stabilize the bone segment. See ’555 patent, col. 8, ll. 35-57; Innova, 381
F.3d at 1118-19 (looking to the body of the claim to understand the purpose). Although
the written description does not define “operatively,” it consistently describes the
purpose of the device to be for posterior stabilization. See ’555 patent, col. 1, ll. 9-12
(“This invention relates generally to an apparatus for immobilization of the spine, and
more particularly, to an apparatus for posterior internal fixation of the spine . . . .”);
Innova, 381 F.3d at 1118-19 (looking to the written description to understand the
purpose). It discusses disadvantages of prior art spinal fixation methods and
apparatuses, ’555 patent, col. 1, ll. 13-64; col. 2, l. 36–col. 3, l. 25, details how the
invention’s features provide an advantageous fixation system, id., col. 3, l. 26–col. 6, l.
44, and provides a method of spinal fixation therapy for use with the device, id., col. 6, l.
45–col. 7, l. 50. Therefore, from the context of the written description, it is clear that one
of ordinary skill in the art would have understood “operatively” to mean effective to
produce posterior stabilization. The district court erred in construing “operatively” to
mean “surgically.” Because the only way a “fixation device” can provide “posterior
stabilization” is through a surgical procedure, construing “operatively” to mean
“surgically” renders the word superfluous, as used in the claim.
For all of these reasons, we modify the district court’s claim construction and
conclude that, in claim 5, the “lower bone interface [is] operatively joined to said bone
segment” when the interface and the bone segment are connected and in contact such
that the device is effective to perform posterior stabilization.
05-1043 20
3. “securing means”
The district court considered the “securing means” limitation to be in § 112, ¶ 6
form, and described its function as “appl[ying] a force to the rod, which compresses the
rod against the anchor seats and secures the rod in place.” Infringement Opinion at 6.
The district court explained that compression must be applied on “either side”—either
inside or outside—of the rod-receiving channel. Id. at 7. The district court identified the
corresponding structure as an “outer nut.” Id. at 6.
Medtronic argues that the district court’s interpretation of the function of the
“securing means” somehow ignores the claim language: “through the application of
substantially equal compressive forces . . . applied on either side along said longitudinal
axis of said channel.” ’555 patent, col. 8, ll. 54-57 (emphasis added). Medtronic asserts
that this language mandates that forces be applied along the longitudinal axis of the rod
on “either side” of the channel and not on “either side” of the vertical axis. Medtronic
interprets “either side” of the channel to be on the “outside” of the channel. Although
Medtronic does not dispute that the corresponding structure is an external nut,
Medtronic argues that the written description and prosecution history show a disavowal
of equivalents to an external nut.
Cross Medical responds that the district court did not ignore the “either side”
limitation, and that, in any event, “either side” can mean that the forces are applied
“inside” the channel. Cross Medical provides the illustration that standing on “either
side” of the room would connote standing inside the room. Cross Medical adds that the
specification and prosecution history do not evince a disavowal, and that claim
differentiation doctrine supports structural equivalents.
05-1043 21
The claim requires:
at least two anchors and an elongated stabilizer comprising a rod having a
diameter and a longitudinal axis . . . .
securing means which cooperate with each of said anchor seat
portions . . . said securing means including second threads which
cooperate with the first threads of the seat means to cause said rod to
bear against said channel through the application of substantially equal
compressive forces by said securing means in the direction of the vertical
axis and applied on either side along said longitudinal axis of said channel.
’555 patent, col. 8, ll. 36-37, 44-57.
We agree with the parties that the limitation is in § 112, ¶ 6 format. See Rodime,
174 F.3d at 1302 (noting that a concession by the parties that the claim is in § 112, ¶ 6
form does not relieve the court of its duty to examine whether § 112, ¶ 6 applies). The
claim recites “securing means,” which gives rise to the presumption that § 112, ¶ 6
applies. See id. The function is “to cause said rod to bear against said channel through
the application of substantially equal compressive forces by said securing means in the
direction of the vertical axis and applied on either side along said longitudinal axis of
said channel.” ’555 patent, col. 8, ll. 53-57.
“[E]ither side” does not refer to “either side” of the rod on the vertical axis of the
channel perpendicular to the rod, because that interpretation would render the “in the
direction of the vertical axis” language redundant. The “and” in the phrase “in the
direction of the vertical axis and applied on either side” makes that clear. Therefore, the
function is to cause the rod to bear against the rod-receiving channel by applying a
compressive force in the direction of the vertical axis while ensuring that substantially
equal forces are applied along the longitudinal axis of the rod on opposite sides—either
inside or outside—of the rod-receiving channel.
05-1043 22
We must now determine whether the claim recites structure to carry out that
function. The claim states that the “securing means . . . cooperate with each of said
anchor seat portions,” id., ll. 44-45, in that the “securing means include[s] second
threads which cooperate with the first threads of the seat means to cause [the desired
function],” id., ll. 51-57. Although it is the operation of the threads that causes the rod to
bear against the channel by applying a compressive force in the direction of the vertical
axis, a naked incantation of threads alone does not ensure that substantially equal
forces are applied along the longitudinal axis of the rod on opposite sides of the rod-
receiving channel. Because there is insufficient structure recited for performing the
specified function, § 112, ¶ 6 applies. Thus, we construe the claim “to cover the
corresponding structure . . . described in the specification and equivalents thereof.”
The structure for performing the recited function is described as follows:
The nut 27 includes internal threads 83 which engage the external
threaded area 76 on the anchor seat. The nut 27 is a hex nut which can
be tightened relative to the seat 25.
As the nut 27 is rotated about the anchor seat 25, it cooperates with
the top side of the flange 46,47 to tighten the clamp 25 in relation to the
rod support 23. The rod 18 is grasped in the tunnel 84 formed between
the rod-receiving channel 54 of the anchor seat 23 and the arch 72 of the
cap 25.
The threads 76 on the anchor seat 23 extend downwardly on the
seat below the top of the cylindrical surface of the rod 18 as is shown in
FIG. 2 and the nut 27 has a relatively constant diameter through the bore
as is shown in FIGS. 2 and 4. Accordingly, the nut 27 can be screwed
directly onto the anchor seat 23 to compressively hold the rod without the
cap 25.
‘555 patent, col. 6, ll. 9-24. Figures 5 and 7 depict the rod 18 in the channel created by
the anchor seat 23, with the nut 27 securing the rod in place. Thus, the structure that
corresponds to the claimed function is a nut with internal threads cooperating with the
05-1043 23
external threads of the anchor seat (an “external nut”). The claim covers that structure
and equivalents thereof.
We are not persuaded by Medtronic’s argument that the written description
shows a disavowal of equivalents. Although we need not decide that there can never
be a disavowal of § 112, ¶ 6 equivalents, “§ 112-6 was written precisely to avoid a
holding that a means-plus-function limitation must be read as covering only the means
disclosed in the specification.” D.M.I., Inc. v. Deere & Co., 755 F.2d 1570, 1574 (Fed.
Cir. 1985). In this case, the inventors were merely describing the structure that
performs the claimed function.
Nor are we persuaded that the prosecution history shows a disavowal. In an
August 4, 1994 Office Action (“Office Action”), the Examiner rejected the apparatus
claims, in part, under § 112, ¶ 1, because “[t]he specification fail[ed] to provide an
enabling description of the embodiment of the action device excluding the cap/cap
means,” and because “language directed toward the ‘securing means’ cooperating with
the seat means through application of compressive forces by the securing means” failed
to have support in the specification. Office Action at 4. Subsequent to that rejection, an
interview was held with the Examiner and the Examiner Interview Summary referred to
“securing means” as “i.e., the nut.” In addition, Remarks in the April 27, 1995
Amendment (“Amendment”) stated that Applicant amended the claims “to define the
anchor seat means having a channel and threads which cooperate with the securing
means (i.e., the nut) so as to capture the stabilizer between the channel and the
securing means.” Amendment at 4. However, Applicant did not add language in claim
5 that limited securing means to a nut. The statements referring to “securing means” as
05-1043 24
“i.e., the nut” simply help to provide the requisite linkage between the function recited in
the claim and the “corresponding” structure. See Default Proof Credit Card Sys., Inc. v.
Home Depot U.S.A., Inc., 412 F.3d 1291, 1298 (Fed. Cir. 2005) (“A structure disclosed
in the specification qualifies as “corresponding” structure only if the specification or
prosecution history clearly links or associates that structure to the function recited in the
claim.”). Applicant did not disclaim all structural equivalents.
Therefore, the district court correctly construed the “securing means” limitation to
refer to the external nut described in the written description. Under § 112, ¶ 6, the claim
also covers equivalents thereof.
4. “bear against said channel”
The parties dispute whether the language of claim 5 reciting that the
“rod . . . bear[s] against said channel” precludes the presence of any intervening
structure between the rod and the channel. The district court held that “[t]here is
nothing in the [language of claim 5] which excludes an anchor channel composed of
more than one component part.” Infringement Opinion at 8. Medtronic argues that the
district court’s construction is erroneous, and that by placing a separable crown member
over the anchor seat, Medtronic has prevented the rod from “bear[ing] against [the]
channel” as a matter of law. Medtronic asserts that the anchor seat must form the
channel and the crown is not part of the anchor seat. Cross Medical responds that
claim 5 does not require that the channel of the anchor seat be a unitary component
and thus does not preclude a finding that the crown is part of the anchor seat.
The dispute reduces to whether the “channel” must be formed in a unitary
structure. The claim requires that the anchor seat means have “an anchor seat portion
05-1043 25
spaced apart from said bone interface including a channel to receive said rod,” ’555
patent, col. 8, ll. 41-42, and that the “securing means . . . cause[s] said rod to bear
against said channel,” id., ll. 51-54. The claim does not state that the anchor seat
portion forming the channel is unitary. Although the sole embodiment described in the
specification depicts a unitary structure, id., col. 5, ll. 20-21, the mere depiction of a
structural claim feature as unitary in an embodiment, without more, does not mandate
that the structural limitation be unitary. See CCS Fitness, Inc. v. Brunswick Corp., 288
F.3d 1359, 1367 (Fed. Cir. 2002) (holding that “member” encompassed a multi-
component structure where the preferred embodiment showed a single-component
structure, but the specification did not otherwise require a certain number of
components). There is nothing in the written description or prosecution history that
limits the channel to being formed in a single-component structure. Thus, the district
court correctly concluded that the “bear against said channel” language of claim 5 does
not exclude an “anchor seat portion” composed of multiple components.
D. Infringement
The district court ruled as a matter of law that the accused devices met the
“operatively joined,” “securing means,” and “bear against said channel” limitations, that
Medtronic was a direct infringer, and that alternatively, Medtronic either contributed to
infringement or induced infringement. Infringement Opinion at 4-9. Medtronic appeals.
05-1043 26
1. “operatively joined”
The district court held that the accused devices met the “operatively joined”
limitation as a matter of law because “‘the accused device, to be infringing, need only be
capable of operating in the [infringing] mode . . . actual [infringing] operation in the
accused device is not required.’” Id. at 5-6 (quoting Intel Corp. v. U.S. Int’l Trade
Comm’n, 946 F.2d 821, 832 (Fed. Cir. 1991)). The district court cited Hilgraeve Corp. v.
Symantec Corp., 265 F.3d 1336, 1343 (Fed. Cir. 2001), for the proposition that “an
accused device may be found to infringe if it is reasonably capable of satisfying the
claim limitations, even though it may also be capable of non-infringing modes of
operation.” Infringement Opinion at 5. The court explained that Medtronic’s devices
“are capable of operative joinder to the bone segment, and are sometimes used in this
way.” Id. at 5-6. In response to Medtronic’s argument that it could not directly infringe
because it did not perform surgery, the district court held that “under 35 U.S.C. § 271
Defendants can be liable for inducing the infringement or for selling a device which
constitutes part of the invention.” Id. at 8.
Medtronic argues that it does not itself make an anchor seat which contacts bone
and it does not perform surgery. Medtronic asserts that Intel and Hilgraeve are
inapposite and that it cannot be a direct infringer simply because its accused devices
are capable of being made into infringing devices by surgeons. Medtronic adds that it
does not induce or contribute to infringement because there is no evidence of
physicians bringing the receiver member into contact with the bone segment to make
the claimed apparatus; because Medtronic does not design the receiver member to
05-1043 27
contact the bone segment; and because Medtronic instructs surgeons not to place the
device into contact with the bone.
Cross Medical counters that to directly infringe, Medtronic need only make
devices that are capable of being converted into infringing devices, citing Intel,
Hilgraeve, and Bell Com. Research Inc. v. Vitalink Com. Corp., 55 F.3d 615 (Fed. Cir.
1995). Cross Medical asserts that Medtronic’s argument that it does not directly infringe
because it does not perform surgery is as superficial as the non-infringement argument
concerning the “Commissioner.com” product in Fantasy Sports Props., Inc. v.
SportsLine.com, Inc., 287 F.3d 1108 (Fed. Cir. 2002), and therefore must fail.
Furthermore, Cross Medical argues that Medtronic’s representatives are present in the
operating room and thus that Medtronic performs surgery. Alternatively, Cross Medical
argues that Medtronic induces infringement because it sells devices to surgeons,
designs its anchors to function when in contact with bone, and intends that surgeons
bring the anchor seat into contact with bone; and because surgeons actually bring the
anchor seat into contact with bone. Cross Medical asserts that Medtronic is a
contributory infringer because it has not proven that there are substantial non-infringing
uses.
“[W]hoever without authorization makes, uses, offers to sell, or sells any patented
invention, within the United States or imports into the United States any patented
invention during the term of the patent therefor [directly] infringes the patent.” 35 U.S.C.
§ 271(a) (2000). To prove direct infringement, the plaintiff must establish by a
preponderance of the evidence that one or more claims of the patent read on the
accused device literally or under the doctrine of equivalents. Advanced Cardiovascular
05-1043 28
Sys., Inc. v. SciMed Life Sys., Inc., 261 F.3d 1329, 1336 (Fed. Cir. 2001). “Literal
infringement requires that each and every limitation set forth in a claim appear in an
accused product.” Franks Casing Crew & Rental Tools, Inc. v. Weatherford Int’l, Inc.,
389 F.3d 1370, 1378 (Fed. Cir. 2004) (internal citation omitted). Claim 5 of the ’555
patent is an apparatus claim. See ’555 patent, col. 8, ll. 34-57. We held in Part II.C.2
supra that the “operatively joined” limitation requires that “the interface and the bone
segment are connected and in contact such that the device is effective to perform
posterior stabilization.”
In support of its argument that Medtronic directly infringes, Cross Medical cites
evidence that Medtronic’s representatives appear in the operating room, identify
instruments used by surgeons, and thus in effect “join” the anchor seat to the bone.
Cross Medical argues that the situation is analogous to those in which courts have
found a party to directly infringe a method claim when a step of the claim is performed
at the direction of, but not by, that party. See, e.g., Shields v. Halliburton Co., 493 F.
Supp. 1376, 1389 (W.D. La. 1980). However, if anyone makes the claimed apparatus,
it is the surgeons, who are, as far as we can tell, not agents of Medtronic. Because
Medtronic does not itself make an apparatus with the “interface” portion in contact with
bone, Medtronic does not directly infringe.
Nor does Intel support a finding of direct infringement. The claim at issue in Intel
called for a “programmable selection means” and thus required only that an accused
device be capable of operating in the enumerated mode. 946 F.2d at 832; see Fantasy
Sports, 287 F.3d at 1117-18; High Tech Med. Instrumentation Inc. v. New Image Indus.,
Inc., 49 F.3d 1551, 1555-56 (Fed. Cir. 1995). Here, the claim does not require that the
05-1043 29
interface be merely “capable” of contacting bone; the claim has a structural limitation
that the anchor seat be in contact with bone. See Fantasy Sports, 287 F.3d at 1117-18
(stressing the “programmable” language of the claim at issue in Intel and holding that
Intel “does not stand for the proposition . . . that infringement may be based upon a
finding that an accused product is merely capable of being modified in a manner that
infringes the claims of a patent”); High Tech, 49 F.3d at 1555-56 (distinguishing Intel
based on the permissive language of the claim at issue). Cross Medical would
distinguish High Tech by asserting that the device in that case had to be physically
altered to become infringing, while Medtronic’s device need not be altered. However,
Cross Medical again fails to recognize that the limitation—the anchor seat being in
contact with bone—is absent until the screw and anchor are put in place during surgery.
Bell Communications and Hilgraeve are also inapposite. In Bell
Communications, plaintiff asserted that defendant’s product embodied a claimed
method, but the district court granted summary judgment of non-infringement reasoning
that the product had non-infringing modes of operation. 55 F.3d at 618-19. In
Hilgraeve, plaintiff asserted that defendant sold software that, when in operation,
infringed plaintiff’s method claim, but the district court granted summary judgment of
non-infringement based on rationale similar to that in Bell Communications. See
Hilgraeve, 265 F.3d at 1339-40. In both cases on appeal, this court held that the district
court had erred by overlooking the rule that “an accused product that sometimes, but
not always, embodies a claimed method nonetheless infringes.” Bell, 55 F.3d at 622-
23; accord Hilgraeve, 265 F.3d at 1343 (“[S]o too the sale of a device may induce
infringement of a method claim even if the accused device is capable of non-infringing
05-1043 30
modes of operation in unusual circumstances.”). However, a rule that governs
infringement of a method claim may not always govern infringement of an apparatus
claim. See, e.g., NTP, Inc. v. Research in Motion, Ltd., 418 F.3d 1282, 1317-18 (Fed.
Cir. 2005) (distinguishing between method claims and apparatus claims for the purpose
of determining infringement under section 271(a)). To infringe an apparatus claim, the
device must meet all of the structural limitations. See Hewlett-Packard Co. v. Bausch &
Lomb, Inc., 909 F.2d 1464, 1468 (Fed. Cir. 1990) (“[A]pparatus claims cover what a
device is, not what a device does.”); In re Michlin, 256 F.2d 317, 320 (C.C.P.A. 1958)
(“It is well settled that patentability of apparatus claims must depend upon structural
limitations and not upon statements of function.”). In this case, claim 5 is an apparatus
claim which contains the structural limitation that the anchor seat contact bone. Cross
Medical has not proven that Medtronic makes an apparatus with an anchor seat in
contact with bone.
Cross Medical’s reliance on Fantasy Sports is also misplaced. In Fantasy
Sports, the apparatus claim called for “[a] computer for playing football.” 287 F.3d at
1111. The district court found that the accused “Commissioner.com” product did not
infringe because it was a “modifiable software tool,” not a computer for playing football.
See id. at 1118. We disagreed, holding that Sportsline directly infringed by making or
using the apparatus because no reasonable juror could find that the
“Commissioner.com” product was not software installed on a computer. See id. at
1118-19. Cross Medical argues that the theory that Medtronic does not directly infringe
because it does not itself contact the anchor seat to the bone is as superficial as
Sportsline’s theory that its product was software but not a computer. However, unlike in
05-1043 31
Fantasy Sports, in this case, no reasonable juror could find that the accused infringer
itself makes or uses the entire claimed apparatus. The anchor seat of the device does
not contact bone until the surgeon implants it.
Because Medtronic is not a direct infringer, we next consider whether Medtronic
induces or contributes to infringement. Under § 271(b), “[w]hoever actively induces
infringement of a patent shall be liable as an infringer.” 35 U.S.C. § 271(b). “‘In order to
succeed on a claim of inducement, the patentee must show, first that there has been
direct infringement,’ and ‘second, that the alleged infringer knowingly induced
infringement and possessed specific intent to encourage another’s infringement.’”
MEMC Elec. Materials, Inc. v. Mitsubishi Materials Silicon Corp., 420 F.3d 1369, 1378
(Fed Cir. 2005) (quoting Minn. Mining & Mfg. Co. v. Chemque, Inc., 303 F.3d 1294,
1304-05 (Fed. Cir. 2002)). Under § 271(c), “[w]hoever offers to sell or sells within the
United States . . . a component of a patented machine, manufacture, combination or
composition . . . constituting a material part of the invention, knowing the same to be
especially made or especially adapted for use in an infringement of such patent, and not
a staple article or commodity of commerce suitable for substantial noninfringing use,
shall be liable as a contributory infringer.” 35 U.S.C. § 271(b). In order to succeed on a
claim of contributory infringement, in addition to proving an act of direct infringement,
plaintiff must show that defendant “knew that the combination for which its components
were especially made was both patented and infringing” and that defendant’s
components have “no substantial non-infringing uses.” Golden Blount, Inc. v. Robert H.
Peterson Co., 365 F.3d 1054, 1061 (Fed. Cir. 2004) (internal quotations omitted).
05-1043 32
As to the predicate act of direct infringement, we conclude that there is a genuine
issue of material fact as to whether surgeons infringe by making the claimed apparatus.
The only evidence that Cross Medical cites suggesting that the anchor seat contacts
bone is the statement of Medtronic’s employee, Michael Sherman, during his January
29, 2004 deposition:
Q. How far down do you screw the screw initially?
A. Well, it depends. Because if you screw these screws all the way
down, they stop rotating. And the rotating around the ball is a feature of
the screw. So you lose some of your ability to rotate, or your freedom.
Because the reason these screws have multiple angles is to make
it easier to assemble the system in the patient. So if you screw these
things down super-tight, you may have – you know, you’ve eliminated the
multiaxial capability of the screw.
So the surgeon in his judgment gets it down, and I like to tell them,
as far as they feel comfortable doing and still have some rotation.
Because the further in the instrumentation is into the patient, the lower –
the closer the instrumentation is to the loads, and thus the lower the
bending moments are on the instrumentation and the less likelihood of
metal failure.
Q. In practice, in some instances the screw is screwed down such that
the receiver touches the bone; is that right?
A. I’m sure some surgeons do that. And it can touch the bone and still
move a little because the bone is elastic. And the tissue right on top of the
bone isn’t necessarily bone. It’s periosteum. It’s deformable.
Medtronic counters with an April 22, 2004, declaration from Kevin Foley, M.D., a board
certified neurosurgeon, who has performed over 500 operations using Medtronic’s
allegedly infringing products. Dr. Foley states, in pertinent part, that:
[i]n all of the surgeries I perform using Medtronic Products, I try to
minimize or avoid contact of any part of the receiver member to the
patient’s spinal anatomy to ease the eventual implantation of the rod. I do
not count on any type of direct connection between the receiver member
and the patient’s spine to impart any stability to the spine or to the implant
construct. . . .
When implanting the Medtronic Products in a patient’s spine, any
contact between the receiver member and any portion of the patient’s
anatomy is incidental to the surgery and not intended to impart any
stability to the spine. In fact, when I instruct other spine surgeons in how
05-1043 33
to implant the Medtronic Products, I tell them that if they tighten down on
the bone screw enough to bring the receiver member into engagement
with the spine, they should back off the bone screw by one-quarter to one-
half turn so as to better enable alignment of the receiver members with the
rod.
Thus, Sherman—who is not testifying that he witnessed contact—speculates that
some surgeons may bring the receiver member into contact with bone. Dr. Foley
confirms that from time to time, “incidental to the surgery,” the receiver member comes
into contact with bone. However, Dr. Foley also suggests that he “tr[ies] to minimize or
avoid contact” and instructs others to “back off the bone screw by one quarter to one-
half turn” “if they tighten down on the bone screw enough to bring the receiver member
into engagement with the spine.”
On the one hand, drawing inferences in favor of Medtronic, a reasonable juror
could conclude that the apparatus is not made because, more likely than not, there is no
contact between the receiver member and the bone. On the other hand, drawing
inferences in favor of Cross Medical, a reasonable juror could conclude that the
apparatus is made by surgeons. Sherman’s statements suggest that the device is
capable of posterior stabilization when the receiver member contacts bone, and the
statements of both Sherman and Dr. Foley suggest that there may be some contact
between the receiver member and the spine. We leave it to the fact finder to decide
whether surgeons directly infringe.
As to inducement, there is a genuine issue of material fact both as to whether
Medtronic “knowingly induced infringement” and as to whether Medtronic “possessed
specific intent to encourage [the surgeons’] infringement.” On the one hand, in the
record are Medtronic’s “Field Bulletins” instructing surgeons that the proper technique
05-1043 34
for installation of the Medtronic device is with the receiver member not in contact with
the bone. Medtronic asserts that these materials, together with Dr. Foley’s statement,
show that it had no knowledge that the surgeons made the claimed apparatus and that
it had no specific intent to encourage infringement. On the other hand, Cross Medical
points to Sherman’s statements—that he would instruct surgeons to screw the receiver
member down “as far as they feel comfortable doing and still have some rotation” and
that “[the receiver member] can touch the bone and still move a little because the bone
is elastic”—as evidence that Medtronic anticipated that surgeons would contact bone
and intended that the device function when in contact with bone. Drawing inferences in
favor of Medtronic, a reasonable juror could find that Medtronic did not know that
surgeons make the claimed apparatus and, moreover, did not specifically intend for
surgeons to contact bone with the anchor seat. Drawing inferences in favor of Cross
Medical, a reasonable juror could find that Medtronic designed its device to function
when the anchor seat contacted bone, anticipated that surgeons would contact the
anchor seat to bone, and thus intended for the surgeon to make or use the apparatus as
claimed.
As to contributory infringement, there is a genuine issue of material fact as to
whether there are substantial non-infringing uses of Medtronic’s devices, specifically,
uses of the devices with no receiver member-to-bone contact. Drawing inferences in
favor of Medtronic, a reasonable juror could conclude, based on Dr. Foley’s statements,
that a substantial number of surgeries occur in which the claimed apparatus is not made
or used, as surgeons are able to avoid contact between the seat and bone. Drawing
inferences in favor of Cross Medical, a reasonable juror might also conclude that in
05-1043 35
almost every surgery, the claimed apparatus is made or used, as some contact between
the receiver member and the bone is incidental.
Therefore, the district court erred in ruling both that there were no genuine issues
of material fact as to infringement and that Medtronic infringed as a matter of law.
2. “securing means”
The district court ruled that Medtronic’s “set screw” is equivalent to the external
nut as a matter of law because it performs compression in “substantially the same way”
to achieve “substantially the same result” as the “external nut.” Infringement Opinion at
6. The district court cited testimony that the set screw has opposite points of contact on
the rod 180 degrees apart, noted that the screw is intended to be coaxial with the
anchor means, and explained that “[a]lthough Plaintiff does not provide tests showing
the magnitude of the force on either side, everything before the Court supports the
conclusion the forces are substantially equal.” Id. at 7. The district court added that
“[d]efendants submit[ed] no evidence to show the forces are not equal.” Id. The district
court reasoned: “[v]iewing the devices themselves and the testimony, it appears
Defendants’ inner screw meets the limitation applying substantially equal compressive
forces on either side of the channel.” Id.
Medtronic argues that a set screw is not equivalent to an external nut as a matter
of law, citing Chiuminatta Concrete Concepts Inc. v. Cardinal Industries, Inc., 145 F.3d
1303 (Fed. Cir. 1998). Medtronic notes that the ’555 patent’s express reference to the
use of a set screw to attach a cross-link to the rod, but lack of a reference to a set screw
to lock the rod to the anchor seat, is compelling evidence of non-equivalents. In
addition, Medtronic asserts that set screws and external nuts are not interchangeable
05-1043 36
because set screws apply a “splaying” force to the side walls of the anchor seat while
external nuts do not; an external nut applies compressive forces to the rod in a way that
bows or bends the rod upwardly in the anchor seat channel while the set screw
minimizes this type of load on the rod; and bowing creates a problem in Medtronic’s
devices. Medtronic adds that Dr. Puno, an inventor of the ’555 patent, testified that a
set screw and an external nut were not interchangeable. Medtronic portrays as
unsupported the views of Dr. Villarraga, Cross Medical’s expert, who opined that the set
screw and external nut are interchangeable. Medtronic argues that Cross Medical has
offered no evidence that the set screw applies “substantially equal compressive forces”
to the rod; and asserts that Michael Sherman offered convincing testimony that they do
not. Medtronic asserts that at the least, there is a genuine issue of material fact as to
whether the set screw is an equivalent.
Cross Medical argues that a set screw and external nut perform the function of
compression in substantially the same way—applying a downward force on a rod
achieved by engaging threads of the receiver—to achieve the identical result—securing
the rod in the channel; and that Chiuminatta is distinguishable. Cross Medical cites
evidence that the set screw applies force to opposite sides of the channel. Cross
Medical asserts that, because the compression being applied from the set screw to the
rod would be through absolutely equal forces applied on either side of the channel
absent machining imperfections and patient physiology, if one were to account for these
factors, the forces would be substantially equal. Cross Medical argues that “splaying”
and “bowing” do not affect equivalents and that Dr. Villarraga’s opinion on
interchangeability is properly based on her knowledge of mechanical engineering and
05-1043 37
her examination of the devices. Cross Medical asserts that Dr. Puno’s testimony on
interchangeability is irrelevant. Cross Medical argues that Medtronic admitted in U.S.
Patent No. 6,660,004 (“the ’004 patent”) that the set screw and external nut were
interchangeable. Cross Medical additionally asserts that because Medtronic argued
that a set screw and external nut are equivalent to invalidate claims of another patent,
Medtronic is estopped from asserting that they are not equivalent.
“‘Literal infringement of a § 112, ¶ 6 limitation requires that the relevant structure
in the accused device perform the identical function recited in the claim and be identical
or equivalent to the corresponding structure in the specification.’” Frank’s Casing, 389
F.3d at 1378 (quoting Odetics, Inc. v. Storage Tech. Corp., 185 F.3d 1259, 1267 (Fed.
Cir. 1999)). “Because structural equivalents under § 112, ¶ 6 are included within literal
infringement of means-plus-function claims, ‘the court must compare the accused
structure with the disclosed structure, and must find equivalent structure as well as
identity of claimed function for the structure.’” Id. (quoting Pennwalt Corp. v. Durand-
Wayland, Inc., 833 F.2d 931, 934 (Fed. Cir. 1987) (en banc) (emphasis omitted)). “This
inquiry for equivalent structure under § 112, ¶ 6 examines whether ‘the assertedly
equivalent structure performs the claimed function in substantially the same way to
achieve substantially the same result . . . .’” Id. (quoting Odetics, 185 F.3d at 1267).
At the outset, we conclude that Medtronic is not estopped from challenging
interchangeability. In this case, Medtronic argued that a set screw and external nut are
functionally equivalent for purposes of invalidating claim 10 of the ’237 patent.
However, that argument has no bearing on Medtronic’s challenge to the
interchangeability of a set screw and an external nut with respect to claim 5 of the ’555
05-1043 38
patent because the functions of the “securing means” in claim 5 of the ’555 patent and
claim 10 of the ’237 patent are different. Claim 10 does not require the application of
substantially equal compressive forces to the rod on either side of the channel. See
’237 patent, col. 4, ll. 42-58, ll. 61-63; col. 5, ll. 14-22. Because the positions are not
entirely inconsistent, judicial estoppel does not apply. See Interactive Gift Express, Inc.
v. Compuserve Inc., 256 F.3d 1323, 1345 (Fed. Cir. 2001) (“[A] party will be judicially
estopped from asserting a position on appeal that is directly opposed to a position that
the party successfully urged at trial.” (internal citations omitted)).
As to the merits, the claimed function has two parts: (1) causing the rod to bear
against the channel by applying a compressive force in the direction of the vertical axis;
and (2) ensuring that substantially equal forces are applied along the longitudinal axis of
the rod on opposite sides—either inside or outside—of the rod-receiving channel.
There is no dispute that the set screw applies a compressive force in the direction of the
vertical axis. However, there is a genuine issue of material fact as to whether the set
screw applies substantially equal forces on opposite sides of the channel, and thus
whether there is identity of function.
On the one hand, Cross Medical cites testimony stating that the v-ring on the
bottom of the internal set screws creates two points of contact when the set screws are
compressed against the rod; that the two points of contact between the set screw and
the rod are 180 degrees apart, separated by the drive in the set screw; and that the set
screw is intended to be co-axial with the receiver (but because of manufacturing
tolerances is not co-axial). (Sherman Dep. of Jan. 29, 2004, at 137-41; Sherman Dep.
of Jan. 30, 2004, at 283-84.) On the other hand, Medtronic cites testimony stating that
05-1043 39
Sherman did not know if the load on the points of contact on either side of the v-ring
were equal; that when the implant is functioning in a patient, the screw takes on
additional load from the rod; and that anytime the screw is loaded, load will increase on
one side of the plug such that forces on the two sides would be unequal. (Id. at 365-
66.) Sherman further testified that he did not know if forces would be equal before the
screw and anchor seat were implanted, because manufacturing tolerances might impact
the forces. (Id. at 366-67.) Drawing inferences in favor of Medtronic, a reasonable juror
could find that the forces are not substantially equal on each side of the channel
because of manufacturing tolerances and the additional load placed on the screw by the
rod when implanted. Crediting Cross Medical’s evidence, a reasonable juror could draw
an inference based on Sherman’s testimony that the forces applied to the rod on either
side of the channel are substantially equal.
Moreover, there is a genuine issue of material fact as to whether the set screw
accomplishes the claimed function in substantially the same way as the external nut.
Medtronic has cited the testimony of Dr. Puno stating that he considered using a set
screw in 1990 to hold the rod in place but decided against the set screw because of
splaying concerns. (Puno Dep. of April 9, 2004, at 32, l. 10-36, l. 24.) Dr. Puno stated
that having the side walls of the anchor seat spread apart when the screw was
tightened down would be “a bad thing” and “could end up loosening the connection on
the rod.” (Id. at 35, ll. 7-14.) Although Dr. Puno testified that he thought a set screw
and external nut were interchangeable, he qualified his statement when confronted with
prior deposition testimony to the opposite effect. (Id. at 37, l. 3–41, l. 23.) Dr. Villarraga
stated that the structures were interchangeable because they both could compress a
05-1043 40
rod into a channel, and because other polyaxial devices utilized set screws. (Villarraga
Decl. of April 12, 2004, at 2.) However, Dr. Villarraga neither explained with any
specificity why one of ordinary skill in the art at the time the ’555 patent issued would
believe the structures to be interchangeable, nor did she refer to any testing. (See id.)
Drawing inferences in favor of Medtronic, a reasonable juror could find that the set
screw does not compress the rod in substantially the same way based on Dr. Puno’s
testimony about the potential for splaying and his conscious decision to avoid the set-
screw design. Drawing inferences in favor of Cross Medical, a reasonable juror could
find that the set screw compresses the rod in substantially the same way because both
employ threads as a compression mechanism, and some statements of Drs. Puno and
Villarraga support a finding of interchangeability.
We thus disagree with Medtronic that the equivalents question should be
removed from the trier of fact under Chiuminatta. In that case, we held that no
reasonable juror could conclude that the differences between “soft round wheels” and a
“skid plate” were insubstantial. Chiuminatta, 145 F.3d at 1310. One of the many
reasons that we found no equivalents as a matter of law was that the patent at issue
discussed the use of wheels for another function, but never disclosed that wheels could
perform the same function as the skid plate. Id. In this case, although Medtronic may
argue that the fact finder should draw an inference of no interchangeability based on the
inventors’ explicit reference to set screws to form a cross-link, see ’555 patent, col. 6, ll.
25-44, and their failure to explicitly recognize set screws as a means for securing the
anchor to the bone, we must draw inferences in favor of Cross Medical in evaluating
05-1043 41
Medtronic’s cross-motion for summary judgment. As discussed supra, we believe that
the issue of interchangeability should be left for the trier of fact.
We also reject the other arguments that both sides make in attempting to prevail
on equivalents as a matter of law. First, we reject Cross Medical’s argument that the
’004 patent serves as an admission on interchangeability. Even though the ’004 patent,
which is assigned to an entity related to Medtronic, suggests that an “internally-threaded
nut” is interchangeable with “a set screw or internal plug,” ’004 patent, col. 8, ll. 10-32,
that patent issued in 2003 and is irrelevant to known interchangeability in 1995, when
the ’555 patent issued. See Al-Site, 174 F.3d at 1320 (“[A] structural equivalent under
§ 112 must have been available at the time of the issuance of the claim.”). Second, we
reject Medtronic’s contentions that the lack of “bowing” with the set screw and the
evidence that the external nut does not function to cause “bowing” in Medtronic’s device
are relevant to interchangeability. Even if the external nut causes “bowing” in
Medtronic’s device, it is immaterial to the equivalents analysis because “prevention of
bowing” is not a limitation of claim 5. See Micro Chem., 194 F.3d at 1258 (cautioning
against adopting a function different from that explicitly recited in the claim).
Furthermore, although Medtronic argues that the external nut may not work well in
Medtronic’s products, any impact this might have on the interchangeability analysis is
undercut by a lack of evidentiary support.
In summary, we conclude that there is a genuine issue of material fact with
respect to whether a set screw is equivalent to an external nut. Thus, the district court
erred in deciding equivalents as a matter of law.
05-1043 42
3. “bear against said channel”
Relying on its holding that the channel of the anchor seat could comprise more
than one component, the district court ruled that, even if the crown is free-floating and
not physically joined to the anchor seat because there is no lock between the crown and
the screw, Medtronic’s devices met the “bear against said channel” limitation as a
matter of law. Infringement Opinion at 7-8. The district court considered evidence that
the crown member is physically joined to the anchor seat because it cannot be removed
without breaking the screw. Id. The district court analogized the crown in Medtronic’s
devices to a “pressure disk”—which was physically between the rod and the anchor
seat—that the district court previously had held met the “bear against the channel”
limitation in Cross Medical Products, Inc. v. DePuy Acromed, Inc., No. SA CV 00-876-
GLT (ANx), (C.D. Cal. Feb. 11, 2002). Infringement Opinion at 7.
Medtronic argues that even if the anchor seat can be comprised of multiple
components, as a matter of fact, the crown member in its accused devices is not part of
the channel formed by the anchor seat and, thus, the rod does not bear against the
channel as recited in the claim. Medtronic asserts that the crown is free floating and not
physically or otherwise joined to the receiver; that the crown is either screwed or slid
into the receiver; and that the crown is retained either by a snap ring or by interrupting
the threads on the receiver after the crown is screwed into the receiver. Medtronic adds
that the presence of the crown between the rod and the bone screw causes the receiver
member to become rigidly locked to the screw, which serves a different function than a
channel absent a crown member.
05-1043 43
Cross Medical counters that there is nothing to preclude a finding that the crown
is part of the anchor seat. Cross Medical argues that the crown member is part of the
channel formed by the anchor seat because the crown is assembled into the device
before it is sold, and cannot be removed without damaging the device. Cross Medical
asserts that the crown is physically joined to the receiver, and adds that any difference
in function is irrelevant because claim 5 has no functional limitation.
There is a genuine issue of material fact as to whether the “bear against [the]
channel” limitation is met by the accused products. Sherman testified that in one
product, “the crown member is threaded and screws down into the receiver member
until it passes the threads of the receiver member and then floats freely until locked
down by the rod.” (Sherman Decl. of April 23, 2004, at 3.) Sherman stated that in other
products, “the crown member is maintained in the receiver member by a snap ring that
is designed to allow the crown ‘member’ to float or move freely within a limited range”
before being locked down by the rod. (Id.) Sherman added that the rod touches only
the crown member in each of Medtronic’s products. (Id. at 3-4.) Viewing this evidence
in the light most favorable to Medtronic, a reasonable juror could conclude that the rod
bears only against the crown member, which is separate from the channel in the anchor
seat, and thus the rod does not “bear against” the channel of the anchor seat.
However, a reasonable juror could also find that the crown member is a part of
the channel, and thus that the rod bears against the channel. Cross Medical cites to
evidence that the screw, crown, snap ring, and receiver are assembled as one unit
before the implant arrives to the surgeon. (Sherman Dep. of Jan. 29, 2004, at 123.)
Cross Medical also cites evidence that the snap ring, which holds the crown member
05-1043 44
loosely in place, is damaged if the implant is disassembled. (Id. at 247.) And we agree
with Cross Medical that the function served by the crown member is irrelevant to finding
that this structural limitation is met. See Amstar Corp. v. Envirotech Corp., 730 F.2d
1476, 1482 (Fed. Cir. 1984) (“[M]odifications by mere addition of elements of
function . . . cannot negate infringement . . . .”).
Because there is a genuine issue of material fact as to whether the “bear against
[the] channel” limitation is met, the district court erred in ruling that the accused devices
met this limitation as a matter of law.
E. Invalidity
The district court granted Cross Medical’s cross-motion for partial summary
judgment on all invalidity defenses raised by Medtronic with respect to claim 5 of the
’555 patent, including indefiniteness, anticipation, and obviousness. Medtronic appeals
each of these rulings.
1. Indefiniteness
As noted in Part II.C.3 supra, Medtronic argued that the district court erroneously
interpreted the function of the “securing means” to require that equal forces be applied
along the longitudinal axis of the channel on “either side” of the vertical axis. Medtronic
asserted that the district court’s interpretation would leave “said longitudinal axis”
without a sufficient antecedent basis and render claim 5 indefinite. We construed the
function of the “securing means” limitation as “to cause the rod to bear against the rod-
receiving channel by applying a compressive force in the direction of the vertical axis,
while ensuring that substantially equal forces are applied along the longitudinal axis of
the rod on opposite sides—either inside or outside—of the rod-receiving channel.” We
05-1043 45
agreed with Medtronic that the antecedent basis for “said longitudinal axis” was by
implication the longitudinal axis of the rod. See Slimfold Mfg. Co. v. Kinkead Indus.,
Inc., 810 F.2d 1113, 1116 (Fed. Cir. 1987) (noting that an antecedent basis can be
present by implication). Because the “said longitudinal axis” limitation is not lacking in
antecedent basis, we conclude that the district court did not err in granting Cross
Medical’s motion for summary judgment that claim 5 is not indefinite.
2. Anticipation
The district court held that claim 5 was not anticipated as a matter of law
because claim 5 covers only polyaxial screws and the two prior art references asserted
to be anticipating—U.S. Patent No. 4,763,644 to Webb (“the ’644 patent”) and the
“Bryd-Transpedicular Spinal Fixator”—disclose only monoaxial screws. Invalidity
Opinion at 5. Medtronic’s arguments on anticipation turn entirely upon whether claim 5
covers monoaxial screws. Because we determined in Part II.C.1 supra that claim 5
does not cover monoaxial screws, we conclude that the district court did not err in
granting Cross Medical’s motion for partial summary judgment that claim 5 is not
anticipated.
3. Obviousness
In the district court, Medtronic contended that claim 5 was obvious in view of the
’602 patent, the ’644 patent, and the Byrd device. Invalidity Opinion at 6. The parties
agreed that the ’602 and ’644 patents were prior art, but the district court held that
because Dr. Puno, an inventor on the ’555 patent, also invented the closure mechanism
of the Bryd device, the Bryd device was not prior art. Id. at 6. Focusing on the ’602 and
’644 patents, the district court explained that the ’602 patent and the ’555 patent are
05-1043 46
both polyaxial spinal implant devices. Id. The district court noted that “[t]he only major
difference between the ’602 patent and the ’555 is the ’602 device is tightened from the
bottom and the ’555 is a top-loading nut,” but that “[t]he ’644 patent covers a top-loading
monoaxial spinal implant device.” Id. at 7. However, the district court held that there
was no motivation to combine the ’602 and ’644 references, relying on its prior ruling in
Cross Medical Products, Inc. v. DePuy AcroMed, Inc., No. SA CV 00-876-GLT(ANx)
(C.D. Cal. Jan. 9, 2003).
In AcroMed, the defendant had argued that “the top-loading nut would have been
obvious in light of the problem to be solved, i.e., surgeons having difficulty tightening the
bottom-loading nuts during implantation.” Invalidity Opinion at 7. The district court
“found AcroMed failed to show motivation to combine because ‘the problem was not
discovered by looking at the prior art or the patent itself. . . . It was only discovered
when doctors tried to use the product.” Id. The court cited In re Sponnoble, 405 F.2d
578, 585 (C.C.P.A. 1969), for the proposition that “‘a patentable invention may lie in the
discovery of the source of a problem even though the remedy may be obvious once the
source of the problem is identified.’” Invalidity Opinion at 7.
The district court found that Medtronic offered no evidence that the problem was
disclosed in the prior art. Id. The district court noted that “Defendants cite only the ’555
patent to describe the problem the ’555 patent sought to fix.” Id. The district court
explained that “[a]lthough Defendants argue the clinical investigators identified the
problem with the bottom-loading nut, the investigators’ letters are not prior art.” Id. The
district court acknowledged that “motivation to combine need not be explicit in the prior
art; ‘it can be implicit in the knowledge of one of skill in the art,’” id. (quoting Nat’l Steel
05-1043 47
Car, Ltd. v. Canadian Pac. Ry., Ltd., 357 F.3d 1319, 1337 (Fed. Cir. 2004)), but
reasoned that “[t]his rule does not change the result in this case because it does not
relate to identification of the problem,” id. at 7. The district court then denied
Medtronic’s motion for summary judgment on obviousness and granted Cross Medical’s
cross motion. Id. at 7-8.
Medtronic argues that it presented sufficient evidence that the bottom-tightening-
nut problem was known to those of ordinary skill in the art and that this provides a
motivation to combine the ’644 and ’602 references. Medtronic cites communications
from clinical investigators as evidence of recognition of the problem by those of ordinary
skill in the art, and argues that the district court’s analysis and adoption of the reasoning
in Sponnoble were in error. In addition, Medtronic cites: (a) the ’644 patent as evidence
that bottom-tightening devices then available were problematic to assemble in situ; (b)
U.S. Patent No. 5,261,913 (“the ’913 patent”) as evidence that it was within the
knowledge of one of ordinary skill to use a top-tightening nut; and (c) the ’555 patent as
evidence that prior art polyaxial screws designed with bottom-tightening nuts were
awkward.3 Medtronic argues that even if the ’913 patent does not qualify as prior art, it
3
In a footnote in its opening brief, Medtronic asserts that the district court
erroneously resolved a fact question as to whether Dr. Puno was an inventor of the Bryd
device but never requests relief or provides record cites for its assertions. Medtronic
makes no other reference to the Bryd device with respect to obviousness in its opening
brief. In its response brief, Medtronic asserts that even if Dr. Puno is a joint inventor of
the Bryd device, there is a different set of joint inventors on the Bryd device—Drs. Puno
and Bryd—than on the ’555 patent—Dr. Puno and Mellinger. Medtronic argues that the
two sets of inventors are separate legal entities under In re Kaplan, 789 F.2d 1574,
1575 (Fed. Cir. 1986), and that the Bryd device may be prior art under §§ 102(f) and
103. Medtronic adds that even if the Bryd device is confidential, it evidences knowledge
of those of ordinary skill.
Medtronic has not properly raised the inventorship issue in its opening brief to
warrant relief from this court. See Fuji Photo Film Co. v. Jazz Photo Corp., 394 F.3d
05-1043 48
evidences knowledge of one of ordinary skill in the art. Medtronic asserts that, at the
least, this evidence is enough to create a genuine issue of material fact on motivation to
combine.
Cross Medical counters that Dr. Puno was one of the clinical investigators who
recognized the problem with the ’602 device, that Dr. Puno discovered the problem as
part of his inventive process, and thus that the clinical investigators’ recognition of the
problem is not evidence of a motivation to combine. Cross Medical argues that the ’644
patent does not itself provide reason to apply its teachings to modify the ’602 device
because it discusses prior art assembly problems related to use of a locking nut and
threaded rod to hold the screw. Cross Medical argues that the ’602 device did not use a
threaded rod with a locking nut, and thus the inventors did not confront the same
problem as confronted by the inventors of the ’644 device. Cross Medical asserts that
the ’913 patent cannot evidence knowledge of ordinary skill in the art at the time of the
invention because the application that matured into the ’913 patent was filed two
months after the invention date of the ’555 patent, and that application was not
published for 18 months. Cross Medical cites differences between the ’602 and ’555
patents in addition to the bottom-tightening nut, and asserts that Medtronic submitted no
evidence explaining how the particular structural elements of the ’602 device could be
modified to achieve the structure disclosed in claim 5 as a whole. Cross Medical argues
that Medtronic failed to discuss “trade-offs” to the use of the top-tightening device, and
neglected to discuss secondary considerations.
1368, 1375 n.4 (Fed. Cir. 2005) (holding that this court will not address arguments that
are not properly raised in the opening brief). Nor will this court consider Medtronic’s
new arguments raised for the first time in its reply brief. Id.
05-1043 49
“A claimed invention is unpatentable if the differences between it and the prior art
are such that the subject matter as a whole would have been obvious at the time the
invention was made to a person having ordinary skill in the art.” In re Kotzab, 217 F.3d
1365, 1369 (Fed. Cir. 2000); see 35 U.S.C. § 103. An invention may be a combination
of old elements disclosed in multiple prior art references. Kotzab, 217 F.3d at 1369. In
determining whether a combination of old elements is non-obvious, the court must
assess whether, in fact, an artisan of ordinary skill in the art at the time of invention, with
no knowledge of the claimed invention, would have some motivation to combine the
teachings of one reference with the teachings of another reference. See In re Fulton,
391 F.3d 1195, 1200-02 (Fed. Cir. 2004). Motivation to combine references “may come
explicitly from statements in the prior art, the knowledge of one of ordinary skill in the
art, or, in some cases the nature of the problem to be solved.” Kotzab, 217 F.3d at
1370. “The test for an implicit teaching is what the combined references, knowledge of
one of ordinary skill in the art, and the nature of the problem to be solved as a whole
would have suggested to those of ordinary skill in the art.” Id.
The sole issue before us is whether the district court erred in ruling that there is
no genuine issue of material fact as to whether the subject matter as a whole would
have been obvious to one of ordinary skill in the art at the time of the invention based on
the absence of any evidence of a motivation to combine the ’602 and ’644 references.
We conclude that a genuine issue of material fact exists with respect to motivation to
combine. Cross Medical designated the screw disclosed in the ’602 patent as the “PWB
I” and performed a pilot study testing its use in humans. A paper, entitled “The Puno-
Winter-Bird (PWB) Spinal System for Transpedicular Fixation of the Lumbar Spine,”
05-1043 50
recounted that surgeons participating in the pilot study found the implant design
“tedious,” and that it was “technically difficult to position the wrench when the nut was
tightened, since it required that the nut be advanced from under the rod.” The paper
explained that “[a]lthough [the PWB I] provided satisfactory fixation of the rod, the
design was not ‘user friendly.’” The paper noted that “[a] design improvement was in
order and led to the development of the PWB II.” Other evidence in the record confirms
that surgeons in the pilot study recognized the problem and requested changes. The
surgeons who participated in the pilot included investigators other than inventors of the
’555 patent.
From this evidence, a reasonable juror could conclude that at the time of the
invention, one of ordinary skill in the art could have been motivated to modify the PWB I
in light of the problem to be solved. Giving credit to Medtronic’s evidence, the clinical
investigators recognized the bottom-tightening problem with the ’602 device and
proposed changes. The problem was within the general knowledge of those of ordinary
skill in the art, and thus provided sufficient motivation to navigate the prior art in the
spinal implant field in search of a teaching on how one might modify the ’602 device
away from a bottom-tightening assembly.
The district court erred in discounting the clinical investigators’ recognition of the
problem. “It has long been the law that the motivation to combine need not be found in
prior art references, but equally can be found ‘in the knowledge generally available to
one of ordinary skill in the art.’” Nat’l Steel, 357 F.3d at 1337 (quoting In re Jones, 958
F.2d 347, 351 (Fed. Cir. 1992)). Evidence of a motivation to combine references need
not be in the form of prior art. See id. at 1338-39. Evidence that a person of ordinary
05-1043 51
skill in the art recognized the same problem to be solved as the inventor and suggested
a solution is, at the least, probative of a person of ordinary skill in the art’s willingness to
search the prior art in the same field for a suggestion on how to solve that problem.
See Pro-Mold & Tool Co. v. Great Lakes Plastics, Inc., 75 F.3d 1568, 1573 (Fed. Cir.
1996) (Motivation to combine “may also come from the nature of a problem to be
solved, leading inventors to look to references relating to possible solutions to that
problem.” (citing Application of Rinehart, 531 F.2d 1048, 1054 (C.C.P.A. 1976))); In re
Huang, 100 F.3d 135, 139 n.5 (Fed Cir. 1996) (stating that problem well-known to a
person of ordinary skill in the art would have directed that person of ordinary skill to the
reference teaching the missing elements); see also, e.g., In re Gartside, 203 F.3d 1305,
1320-21 (Fed. Cir. 2000) (recognizing that motivation to combine can come from the
nature of the problem to be solved); In re Rouffet, 149 F.3d 1350, 1355 (Fed. Cir. 1998)
(same). To the extent that the district court determined that the only investigators who
recognized the problem of the bottom-tightening assembly were inventors on the ’555
patent, that conclusion has no basis in the record.
Furthermore, the district court’s reliance on Sponnoble is misplaced. In that
case, those of ordinary skill in the art of packaging pharmaceutical products recognized
a moisture-transfer problem with “structure[s] for temporarily isolating a compartment
containing a solid pharmaceutical product from a compartment containing an aqueous
solution.” Sponnoble, 405 F.2d at 585. The industry believed that moisture was
transmitted around the plug separating the two compartments. Id. at 586. Sponnoble
discovered that moisture traveled through the plug and remedied that problem with a
solution available in the prior art. Id. Our predecessor court held that the invention was
05-1043 52
non-obvious because one of ordinary skill in the art would not have chosen the solution
without recognizing the true cause of the problem, and “the cause of the problem [was]
not suggested by the prior art.” Id. In this case, however, the problem was known to
the clinical investigators at the time of the invention, and thus, unlike Sponnoble, the
problem was within the general knowledge of one of ordinary skill in the art. See Nat’l
Steel, 357 F.3d at 1338 (“Something that has already been rendered obvious to a
newcomer in the field is probative of what would be obvious to someone who has been
around for a longer period of time.”). If the problem is within the knowledge of one of
ordinary skill in the art, then it is irrelevant that the prior art does not disclose the
problem. See id. at 1337-39.
Moreover, we conclude—after drawing inferences in favor of Medtronic—that the
’644 patent itself may have provided sufficient motivation for one of ordinary skill to have
considered its teachings and altered the ’602 device. The ’644 invention was an
improvement over prior art spinal implant devices which used a threaded rod with
locking nuts. In characterizing the prior art, the patent states that “[t]he need to thread
the nut along the rod results in the device being rather slow to assemble and can result
in damage to soft tissue if carried out in situ.” ’644 patent, col. 2, ll. 10-12. The solution
was, in part, a top-tightening nut. See id., col. 3, ll. 16-23; id., Figure 2. Thus, the ’644
patent discusses a problem posed by the assembly of certain spinal stabilization
devices in situ and a solution. Confronted with the implantation problem of the ’602
device, one of ordinary skill might have found the problem solved by the ’644 patent
sufficiently analogous to have been motivated to apply its teachings. In turn, we reject
Cross Medical’s contention that the ’644 device cannot provide the requisite motivation
05-1043 53
because the problem it addressed may have differed slightly from the problem
encountered by surgeons using the ’602 device. One of ordinary skill in the art need not
see the identical problem addressed in a prior art reference to be motivated to apply its
teachings. See In re Oetiker, 977 F.2d 1443, 1448 (Fed. Cir. 1992) (Nies, C.J.,
concurring) (“Such suggestion or motivation to combine prior art teachings can derive
solely from the existence of a teaching, which one of ordinary skill in the art would be
presumed to know, and the use of that teaching to solve the same or similar problem
which it addresses.” (citing In re Wood, 599 F.2d 1032, 1037 (C.C.P.A. 1979))
(emphasis added)); cf. In re Dillon, 919 F.2d 688, 694 (Fed. Cir. 1990) (en banc) (“‘[A
reference is not from a non-analogous art if] the reference is reasonably pertinent to the
particular problem with which the inventor was involved.’” (quoting In re Deminski, 796
F.2d 436, 442 (Fed. Cir. 1986) (quoting in turn from Wood, 599 F.2d at 1036))).
As to the other evidence cited by Medtronic, the ’555 patent suggests that the
inventor recognized the problem of bottom-tightening. However, the patent does not
provide evidence that the problem was within the knowledge of those of ordinary skill in
the art at the time of the invention; or that the problem was disclosed in the prior art.
The ’913 patent is also of limited relevance because it issued after the invention date.
See Mahurkar v. C.R. Bard, Inc., 79 F.3d 1572, 1576-77 (Fed. Cir. 1996).
Thus, we conclude that, because there are genuine issues of material fact on the
underlying facts related to obviousness, the grant of summary judgment was in error.
III. CONCLUSION
We conclude that we have jurisdiction over this appeal. We affirm the district
court’s construction of the “anchoring means,” “securing means,” and “bear against said
05-1043 54
channel” limitations, but modify the district court’s construction of the “operatively joined”
and the “anchor seat means” limitations. Because we find genuine issues of material
fact regarding infringement, we reverse the grant of Cross Medical’s motion for partial
summary judgment of infringement and find no abuse of discretion in the denial of
Medtronic’s cross-motion for partial summary judgment of non-infringement. We also
reverse the grant of Cross Medical’s motion for partial summary judgment that claim 5 is
not obvious but affirm the grant of that motion as to indefiniteness and anticipation. We
further conclude that the district court did not abuse its discretion in denying Medtronic’s
cross-motion for summary judgment as to these invalidity issues. As a result, we vacate
the permanent injunction. We remand for further proceedings consistent with this
opinion.
AFFIRMED-IN-PART, REVERSED-IN-PART, VACATED-IN-PART, AND REMANDED.
COSTS
Costs to Medtronic.
05-1043 55